Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Elinav
Doron Elinav, Ramat-Gan IL
| Patent application number | Description | Published |
|---|---|---|
| 20100309839 | Statistical Multiplexing in a Satellite Communication Networks - A single, large-scale satellite access communication network may be configured as infrastructure for many small-scale subnets, wherein each subnet may be configured to serve a different organization (e.g. an SME) as a private network. Each subnet may be configured as a small star and/or mesh satellite data access network from the end-user perspective, yet all subnets may be configured to be part of the total large-scale network and share satellite bandwidth resources. Such configuration may yield significantly higher bandwidth efficiency, lower operation and equipment costs, minimized latency and ease of network operations for each of the small organizations sharing the large-scale network. | 12-09-2010 |
Eran Elinav, Jerusalem IL
| Patent application number | Description | Published |
|---|---|---|
| 20100135974 | REDIRECTED, GENETICALLY-ENGINEERED T REGULATORY CELLS AND THEIR USE IN SUPPRESSION OF AUTOIMMUNE AND INFLAMMATORY DISEASE - A redirected Treg cell is endowed with specificity toward a selected target antigen or ligand. The cell contains a chimeric receptor polypeptide that is expressed in a single, continuous chain, with an extracellular recognition region displayed on the surface of the cell, a transmembrane region and an intracellular signaling region. The extracellular recognition region is specific for the selected target antigen or ligand. The intracellular signaling region includes a combination of T-cell signaling polypeptide moieties, which combination, upon binding of the extracellular recognition region to the selected target antigen or ligand, triggers activation of the redirected Treg cells to cause suppression of T-cell mediated immunity. Such redirected Treg cells may be used to suppress undesired activity of T effector cells thereby mediating an immune or inflammatory response. They are particularly useful in treating T effector cell-mediated diseases, such as inflammatory bowel disease, transplant rejection and GVH disease. | 06-03-2010 |
Eran Elinav, Ramat Belt Hakerem IL
| Patent application number | Description | Published |
|---|---|---|
| 20110256123 | Methods and uses of leptin in immune modulation and hepatocellular carcinoma - The present invention relates to methods for the modulation of immune responses. More particularly, the invention relates to methods and uses of leptin for immune-modulation of the balance between the Th1/Th2 responses and for the treatment of immune-related disorders. Specifically, the methods of the invention comprise shifting the Th1/Th2 cell balance towards the proinflammatory state. This modulation of the cell balance may be performed by increasing the activity and/or the expression of leptin in a subject, for instance by raising the amount of leptin. The amount of leptin in a subject may be increased by activating immunoregulatory cells, or by administering an immunomodulatory amount of leptin or a homologue, derivative, or functional fragment of leptin. | 10-20-2011 |
Omer Elinav, Emek Hefer IL
| Patent application number | Description | Published |
|---|---|---|
| 20090236335 | Food preparation - Devices and methods for RF heating of food, using techniques which allow uniformity and/or controlled non-uniformity. | 09-24-2009 |